Workflow
宝马进口X3 M40i
icon
Search documents
长安汽车辟谣阿维塔相关谣言,极氪、蔚来起诉“车曝台”胜诉 | 汽车早参
Mei Ri Jing Ji Xin Wen· 2025-04-20 22:30
Group 1 - Changan Automobile refuted rumors regarding its partnership with Huawei, emphasizing its commitment to the collaboration and clarifying that any claims of distancing from Huawei are false [1] - The potential restructuring involving Changan's controlling shareholder, the Equipment Group, may provide future growth momentum for the company and stabilize stock prices [1] Group 2 - Zeekr and NIO won a defamation lawsuit against the self-media platform "Car Exposure Platform," with the court ruling that the platform's actions harmed Zeekr's brand reputation, resulting in a compensation of 300,000 yuan [2] - The legal victories for Zeekr and NIO highlight the importance of brand image and intellectual property protection in the automotive industry, potentially boosting investor confidence [2] Group 3 - Seres announced that its executives and core team members completed a share buyback totaling 248,400 shares, representing 0.0152% of the company's total equity, with an investment of approximately 33.14 million yuan [3] - The share buyback reflects management's confidence in the company's future prospects, which may attract more investor attention in the short term [3] Group 4 - Stellantis and Leap Motor are set to launch a localized assembly project in Malaysia, with an initial investment of 5 million euros (approximately 24 million ringgit), aiming to produce the Leap Motor C10 by the end of 2025 [4][5] - This collaboration indicates both companies' recognition of the Southeast Asian market's potential and aims to enhance their competitive position in the region [4] Group 5 - BMW announced a recall of certain imported models due to a defect in the onboard diagnostic software, affecting 1,291 units of the imported X4 M40i and 2,445 units of the imported X3 M40i [5] - The recall reflects BMW's commitment to product quality and compliance, as the company will provide free software upgrades to mitigate potential safety risks [5][6]